In 99 and 2000 when I was a student at U.C. Berkeley research staff discussed how any stock with the term Genetics or DNA in its title was skyrocketing.
Research is always an area of financial risk, as the supply of ideas can never match the demand for idea driven products.
Ideas can change the way business is done and who does it.
These guys have survived several crashes in the bio-research field and many ideas in their labs are waiting for a market recovery for action to meet the market demand.
This is a hardened business with big upside potential and a moderately good price.
I would buy it again if it fell %10 without hesitation.